Search
+
    SEARCHED FOR:

    NEURALINK TRIAL

    Elon Musk's Neuralink says it has 21 participants enrolled in trials

    This marks an increase from the 12 people the company in September said had received its chips and were using them to control digital and physical tools through thought.

    US DOGE layoffs hit FDA staff reviewing Elon Musk’s Neuralink — What happens next?

    A wave of federal job cuts initiated by the Department of Government Efficiency (DOGE) is impacting regulatory agencies investigating Elon Musk’s companies, including the US Food and Drug Administration (FDA). Employees responsible for overseeing Neuralink’s clinical trial applications were among those dismissed. With staffing reductions slowing down or bypassing regulatory oversight, concerns are growing over potentially weakened safety reviews for Musk’s ventures.

    FDA staff reviewing Musk's Neuralink were included in DOGE employee firings, sources say

    Approximately 20 FDA employees reviewing Neuralink's brain implant applications were dismissed amid a federal workforce purge. The cuts, attributed to performance reasons, will significantly impact the agency’s ability to process medical device applications, raising concerns about the integrity of Neuralink's ongoing trials and participant safety.

    Elon Musk's Neuralink seeks to enroll three patients in brain implant study

    Neuralink, Elon Musk's brain-chip company, is conducting a study to evaluate its device for paralyzed patients to control digital devices through thoughts alone, facing criticism for lack of study information sharing.

    US lawmaker seeks answers on FDA inspection of Musk's Neuralink

    Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer using only their thoughts.

    Elon Musk's Neuralink cited by FDA over animal lab issues

    The inspectors identified quality control lapses at the company's California animal research facility. A similar inspection at Neuralink's Texas facility did not find problems, according to agency records. Those visits took place last year from June 12-22, and represent the FDA's sole inspections of Neuralink facilities on record.

    The Economic Times
    BACK TO TOP
    Advertisement